• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一例伴有CFHR5基因罕见变异的C3肾小球肾炎病例。

A Case of C3 Nephritis With a Rare Variant of the CFHR5 Gene.

作者信息

Kamido Hisashi, Yamamoto Shinya, Yokoi Hideki, Mizuno Masashi, Yanagita Motoko

机构信息

Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, JPN.

Nephrology, Nagoya University, Nagoya, JPN.

出版信息

Cureus. 2024 Feb 27;16(2):e55102. doi: 10.7759/cureus.55102. eCollection 2024 Feb.

DOI:10.7759/cureus.55102
PMID:38558633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978818/
Abstract

C3 nephropathy is a renal disease caused by the aberrant activation of the alternative complement pathway. The long-term renal prognosis of C3 nephropathy is generally poor, and elucidation of its pathogenesis is clinically important. Genetic abnormalities within complement genes, encompassing autoantibodies targeting complement components and complement factor H-related proteins (CFHRs), can lead to abnormal complement activation. is one of the best-known responsible genes for C3 nephritis. Moreover, the renal prognosis can vary depending on the specific type of genetic mutation. Here, we report the case of a young woman with C3 nephritis and a heterozygous rare variant, P453S, in . The P453S variant, characterized by amino acid substitutions with a low allele frequency, was located in the region essential for CFHR5 protein function, and multiple in silico analyses were done suggesting the pathological significance of P453S. The renal function of our patient remains stable. The P453S variant might contribute to the suppression of the CFHR5 protein's function, resulting in gradual complement progression and a favorable renal prognosis.

摘要

C3 肾病是一种由替代补体途径异常激活引起的肾脏疾病。C3 肾病的长期肾脏预后通常较差,阐明其发病机制具有重要的临床意义。补体基因内的遗传异常,包括针对补体成分的自身抗体和补体因子 H 相关蛋白(CFHRs),可导致补体异常激活。 是 C3 肾炎最著名的致病基因之一。此外,肾脏预后可能因基因突变的具体类型而异。在此,我们报告一例患有 C3 肾炎且在 中存在杂合罕见变异 P453S 的年轻女性病例。P453S 变异以低等位基因频率的氨基酸替换为特征,位于 CFHR5 蛋白功能所必需的区域,并且进行了多项计算机模拟分析,提示 P453S 的病理意义。我们患者的肾功能保持稳定。P453S 变异可能有助于抑制 CFHR5 蛋白的功能,导致补体逐渐进展以及良好的肾脏预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d18/10978818/c0cff8d6d269/cureus-0016-00000055102-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d18/10978818/c0cff8d6d269/cureus-0016-00000055102-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0d18/10978818/c0cff8d6d269/cureus-0016-00000055102-i01.jpg

相似文献

1
A Case of C3 Nephritis With a Rare Variant of the CFHR5 Gene.一例伴有CFHR5基因罕见变异的C3肾小球肾炎病例。
Cureus. 2024 Feb 27;16(2):e55102. doi: 10.7759/cureus.55102. eCollection 2024 Feb.
2
The clinical significance of plasma CFHR 1-5 in lupus nephropathy.血浆 CFHR1-5 在狼疮性肾炎中的临床意义。
Immunobiology. 2019 May;224(3):339-346. doi: 10.1016/j.imbio.2019.03.005. Epub 2019 Apr 3.
3
Clinical course and outcome after kidney transplantation in patients with C3 glomerulonephritis due to CFHR5 nephropathy.CFHR5 肾病导致的 C3 肾小球肾炎患者肾移植后的临床病程和结局。
Nephrol Dial Transplant. 2019 Oct 1;34(10):1780-1788. doi: 10.1093/ndt/gfz021.
4
Rare Variants in the Complement Factor H-Related Protein 5 Gene Contribute to Genetic Susceptibility to IgA Nephropathy.补体因子H相关蛋白5基因中的罕见变异导致IgA肾病的遗传易感性。
J Am Soc Nephrol. 2016 Sep;27(9):2894-905. doi: 10.1681/ASN.2015010012. Epub 2016 Jan 29.
5
A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl.一名土耳其女孩中与C3肾小球肾炎相关的一种新型CFHR5突变
J Nephrol. 2014 Aug;27(4):457-60. doi: 10.1007/s40620-013-0008-1. Epub 2013 Dec 5.
6
A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.一种新型CFHR5融合蛋白在一个没有塞浦路斯血统的家族中导致了C3肾小球病。
Kidney Int. 2014 Apr;85(4):933-7. doi: 10.1038/ki.2013.348. Epub 2013 Sep 25.
7
Recurrence of complement factor H-related protein 5 nephropathy in a renal transplant.补体因子 H 相关蛋白 5 肾病在肾移植中的复发。
Am J Transplant. 2011 Jan;11(1):152-5. doi: 10.1111/j.1600-6143.2010.03333.x. Epub 2010 Nov 29.
8
C3 glomerulonephritis and CFHR5 nephropathy.C3 肾小球肾炎和 CFHR5 肾病。
Nephrol Dial Transplant. 2013 Feb;28(2):282-8. doi: 10.1093/ndt/gfs441. Epub 2012 Nov 2.
9
Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.家族性 C3 肾小球病伴 CFHR5 突变:16 个家系中 91 例患者的临床特征。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1436-46. doi: 10.2215/CJN.09541010. Epub 2011 May 12.
10
Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis.鉴定具有肾小球肾炎的塞浦路斯血统患者中的补体因子 H 相关蛋白 5 突变。
Lancet. 2010 Sep 4;376(9743):794-801. doi: 10.1016/S0140-6736(10)60670-8. Epub 2010 Aug 25.

本文引用的文献

1
FHR-5 Serum Levels and Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.免疫复合物介导的膜增生性肾小球肾炎和 C3 肾小球病患者的 FHR-5 血清水平和遗传变异。
Front Immunol. 2021 Sep 10;12:720183. doi: 10.3389/fimmu.2021.720183. eCollection 2021.
2
The solution structure of the complement deregulator FHR5 reveals a compact dimer and provides new insights into CFHR5 nephropathy.补体失调控因子 FHR5 的溶液结构揭示了一个紧凑的二聚体,并为 CFHR5 肾病提供了新的见解。
J Biol Chem. 2020 Nov 27;295(48):16342-16358. doi: 10.1074/jbc.RA120.015132. Epub 2020 Sep 14.
3
C3 Glomerulopathy: Pathogenesis and Treatment.
C3 肾小球病:发病机制与治疗。
Adv Chronic Kidney Dis. 2020 Mar;27(2):104-110. doi: 10.1053/j.ackd.2019.12.003.
4
Update on C3 Glomerulopathy: A Complement-Mediated Disease.C3 肾小球病:一种补体介导的疾病的最新进展。
Nephron. 2020;144(6):272-280. doi: 10.1159/000507254. Epub 2020 May 5.
5
C3 glomerulopathy - understanding a rare complement-driven renal disease.C3 肾小球病——了解一种罕见的补体驱动性肾脏疾病。
Nat Rev Nephrol. 2019 Mar;15(3):129-143. doi: 10.1038/s41581-018-0107-2.
6
C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.在一项美国大型 C3 肾小球病患者队列中,C3 肾小球肾炎和致密物沉积病具有相似的疾病进程。
Kidney Int. 2018 Apr;93(4):977-985. doi: 10.1016/j.kint.2017.10.022. Epub 2018 Jan 6.
7
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.聚类分析确定 C3 肾小球病/免疫复合物介导的膜增生性 GN 中的不同发病模式。
J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13.
8
C3 glomerulopathy and current dilemmas.C3肾小球病与当前的困境
Clin Exp Nephrol. 2017 Aug;21(4):541-551. doi: 10.1007/s10157-016-1358-5. Epub 2016 Nov 23.
9
Dimerization of complement factor H-related proteins modulates complement activation in vivo.补体因子 H 相关蛋白的二聚化调节体内补体激活。
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4685-90. doi: 10.1073/pnas.1219260110. Epub 2013 Mar 4.
10
C3 glomerulonephritis and CFHR5 nephropathy.C3 肾小球肾炎和 CFHR5 肾病。
Nephrol Dial Transplant. 2013 Feb;28(2):282-8. doi: 10.1093/ndt/gfs441. Epub 2012 Nov 2.